Recon Strategy
Contact

Insights

Fifteen+ years of
Healthcare thinking.

Several hundred perspectives on the questions facing payers, providers, biopharma, medtech, and digital health — plus our running read on the clinical literature. Start with our sharpest work, or filter to your world.

Sector
All
NEJM opinion
Stylized representation of digital health

Keys to harnessing the value of digital biomarkers in clinical trials

  • Biopharma , 
  • Medtech , 
  • Digital , 
Digital biomarkers are no longer just a pipe dream—they are here, and their use is potentially at an inflection point. However, successful implementation requires more than enthusiasm; it demands thoughtful strategies tailored to each clinical innovation, therapeutic area, and digital tool.

Read more

Artificial Intelligence for Pipeline Discovery and Beyond

  • Biopharma , 
  • Digital , 
The biopharma industry is known for its high risk and potential high r…

Read more

Advances in AI for Health in 2021: An Analysis of the Clinicaltrials.gov Registry

  • Digital , 
The role of artificial intelligence (AI) and machine learning (ML) in …

Read more

Clinicaltrials.gov and AI-related studies: a brief status check in April 2021

  • Digital , 
Healthcare is by nature conservative; despite a huge level of interest…

Read more

Working paper: the coming age of algorithmic medicine

  • Payers , 
  • Providers , 
  • Digital , 
Summary In this working paper, we develop the following thesis. In the…

Read more

Deploying analytics in a healthcare world flooded with data

  • Digital , 
We live in a society with too much data. In the field of market resear…

Read more